References
- Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol 2015;1:505-27. https://doi.org/10.1001/jamaoncol.2015.0735
- Park JY, Jang SH. Epidemiology of lung cancer in Korea: recent trends. Tuberc Respir Dis 2016;79:58-69. https://doi.org/10.4046/trd.2016.79.2.58
- Shin A, Oh CM, Kim BW, Woo H, Won YJ, Lee JS. Lung cancer epidemiology in Korea. Cancer Res Treat 2017;49:616-26. https://doi.org/10.4143/crt.2016.178
- Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. Biomark Med 2013;7:49-58. https://doi.org/10.2217/bmm.12.111
- Devarakonda S, Morgensztern D, Govindan R. Genomic alterations in lung adenocarcinoma. Lancet Oncol 2015;16:e342-51. https://doi.org/10.1016/S1470-2045(15)00077-7
- Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011;12:861-74. https://doi.org/10.1038/nrg3074
- Zhang Y. Recent progress in the epigenetics and chromatin field. Cell Res 2011;21:373-4. https://doi.org/10.1038/cr.2011.33
- Ansari J, Shackelford RE, El-Osta H. Epigenetics in non-small cell lung cancer: from basics to therapeutics. Transl Lung Cancer Res 2016;5:155-71. https://doi.org/10.21037/tlcr.2016.02.02
- Mehta A, Dobersch S, Romero-Olmedo AJ, Barreto G. Epigenetics in lung cancer diagnosis and therapy. Cancer Metastasis Rev 2015;34:229-41. https://doi.org/10.1007/s10555-015-9563-3
- Hong Y, Ji W, An S, Han SS, Lee SJ, Kim WJ. Sex differences of COPD phenotypes in nonsmoking patients. Int J Chron Obstruct Pulmon Dis 2016;11:1657-62. https://doi.org/10.2147/COPD.S108343
- Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:1865-73. https://doi.org/10.1001/jama.2011.1591
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. https://doi.org/10.1056/NEJMoa1102873
- van der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: latest developments and unanswered questions. Lancet Respir Med 2016;4:749-61. https://doi.org/10.1016/S2213-2600(16)30200-4
- Hubers AJ, Brinkman P, Boksem RJ, Rhodius RJ, Witte BI, Zwinderman AH, et al. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis. J Clin Pathol 2014;67:707-11. https://doi.org/10.1136/jclinpath-2014-202414
- Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 2011;6:1632-8. https://doi.org/10.1097/JTO.0b013e318220ef9a
- Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;91:332-9. https://doi.org/10.1093/jnci/91.4.332
- Xiao P, Chen JR, Zhou F, Lu CX, Yang Q, Tao GH, et al. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. Lung Cancer 2014;83:56-60. https://doi.org/10.1016/j.lungcan.2013.09.008
- Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008;358:1118-28. https://doi.org/10.1056/NEJMoa0706550
- Sandoval J, Mendez-Gonzalez J, Nadal E, Chen G, Carmona FJ, Sayols S, et al. A prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol 2013;31:4140-7. https://doi.org/10.1200/JCO.2012.48.5516
- Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 2007;110:2019-26. https://doi.org/10.1002/cncr.23001
- Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, et al. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 2007;96:1278-83. https://doi.org/10.1038/sj.bjc.6603721
- Stirzaker C, Taberlay PC, Statham AL, Clark SJ. Mining cancer methylomes: prospects and challenges. Trends Genet 2014;30:75-84. https://doi.org/10.1016/j.tig.2013.11.004
- Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 2009;1:177-200. https://doi.org/10.2217/epi.09.14
- Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, et al. Critical evaluation of the Illumina Methylation-EPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol 2016;17:208. https://doi.org/10.1186/s13059-016-1066-1
- Qiao H, Prasada Rao HB, Yang Y, Fong JH, Cloutier JM, Deacon DC, et al. Antagonistic roles of ubiquitin ligase HEI10 and SUMO ligase RNF212 regulate meiotic recombination. Nat Genet 2014;46:194-9. https://doi.org/10.1038/ng.2858
- Sandor C, Li W, Coppieters W, Druet T, Charlier C, Georges M. Genetic variants in REC8, RNF212, and PRDM9 influence male recombination in cattle. PLoS Genet 2012;8:e1002854. https://doi.org/10.1371/journal.pgen.1002854
- Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143-53. https://doi.org/10.1056/NEJMra0802968
- Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004;23:1000-4. https://doi.org/10.1038/sj.onc.1207256
- Rosell R, Skrzypski M, Jassem E, Taron M, Bartolucci R, Sanchez JJ, et al. BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS One 2007;2:e1129. https://doi.org/10.1371/journal.pone.0001129
Cited by
- TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer vol.10, 2020, https://doi.org/10.1038/s41598-020-67325-7
- Biomarkers and diagnostic tools for lung cancer vol.64, pp.1, 2019, https://doi.org/10.5124/jkma.2021.64.1.66
- Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets vol.22, pp.21, 2019, https://doi.org/10.3390/ijms222111701